What Multinational Companies Need To Know About China's New GMP Regs - Webinar (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's new good manufacturing practices regulations that went into effect March 1 significantly raise drug manufacturing standards in almost all areas, and shift the focus of China GMPs to a risk-based quality approach. But more importantly, the new regs indicate how China's State FDA views GMPs and the specific areas that will see more regulatory focus